Check out our most popular compounded medications! Get Started
This troche is a compounded formulation of Estriol, Estradiol, and Estrone in an 80%-10%-10% ratio, with dosages ranging from 0.625-2.5 mg. It also contains Progesterone (50-100 mg) and Testosterone (0.125-2 mg). It is primarily used for the treatment of menopausal symptoms, endometriosis, uterine fibroids, polycystic ovary syndrome, and hypogonadism.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
This troche formulation is a compounded blend of estrogens, namely estriol, estradiol, and estrone, in an 80%-10%-10% ratio. It also contains progesterone and testosterone. The dosage ranges for these hormones are as follows: estrogens are present in a 0.625-2.5 mg range, progesterone in a 50-100 mg range, and testosterone in a 0.125-2 mg range. This formulation is primarily used to manage a variety of conditions, including menopausal symptoms, postmenopausal osteoporosis, and hypoestrogenism.
The combination of estrogens in this formulation works synergistically to alleviate menopausal symptoms such as hot flashes, night sweats, and vaginal dryness. The inclusion of progesterone is crucial as it helps to mitigate the risk of endometrial hyperplasia and cancer. Testosterone, on the other hand, is known to enhance libido and energy levels. Collectively, these hormones work together to reduce the risk of postmenopausal osteoporosis, a common condition in women after menopause.
This troche formulation is a square-shaped solid dosage form designed to dissolve slowly in the mouth. The medication is delivered through oral mucosa absorption, allowing for targeted local or systemic effects. This method of delivery ensures a steady release of hormones, providing consistent relief from symptoms.
It is important to use this medication as directed by a healthcare professional and to report any adverse effects promptly. If you have any questions or concerns about this formulation, please do not hesitate to reach out for further information.
This troche formulation of Estriol/Estradiol/Estrone [80%-10%-10%] 0.625-2.5 mg/Progesterone 50-100 mg/Testosterone 0.125-2 mg is a compounded medication designed to address a range of health conditions, including menopausal symptoms, hypogonadism, and postmenopausal osteoporosis. The formulation contains Estriol, Estradiol, and Estrone, all of which are forms of estrogen. These hormones can help alleviate menopausal symptoms such as hot flashes, night sweats, and vaginal dryness. The inclusion of Progesterone in the formulation helps to counterbalance the effects of estrogen and can potentially reduce the risk of endometrial cancer. Testosterone is included to address hypogonadism, a condition characterized by insufficient testosterone production. It can also help reduce the risk of osteoporosis in postmenopausal women.
It's crucial for patients to be aware that this formulation may interact with other medications. These include anticoagulants, anti-seizure medications, and certain antibiotics. Therefore, it's important for patients to inform their healthcare provider of any other medications they are currently taking before starting this formulation. This formulation may also cause side effects such as nausea, headache, and breast tenderness. If patients experience any of these side effects, they should immediately contact their healthcare provider.
If you have any questions or concerns about this formulation or its potential interactions, please don't hesitate to reach out for further information. It's important to us that you feel fully informed and confident in your healthcare decisions.
This troche formulation is a compounded medication that contains estriol, estradiol, and estrone in an 80%-10%-10% ratio, with dosages ranging from 0.625-2.5 mg. It also includes progesterone in doses of 50-100 mg and testosterone in doses of 0.125-2 mg. This combination of hormones is designed to treat a variety of conditions, including menopausal symptoms, postmenopausal osteoporosis, and hypogonadism.
Estriol, estradiol, and estrone are all forms of estrogen, a hormone that plays a crucial role in the regulation of the reproductive system. Estriol, the weakest form of estrogen, is primarily used to alleviate menopausal symptoms such as hot flashes, night sweats, and vaginal dryness. Estradiol, the most potent form of estrogen, is used to treat both menopausal symptoms and postmenopausal osteoporosis. Estrone, the most abundant form of estrogen in postmenopausal women, is also used to manage menopausal symptoms.
Progesterone, another hormone included in this formulation, helps regulate the menstrual cycle and is used to treat menopausal symptoms and postmenopausal osteoporosis. Testosterone, a hormone that regulates the reproductive system, is used to treat hypogonadism, a condition characterized by the body's insufficient production of testosterone.
This troche formulation is designed to be taken orally, typically once or twice a day, and dissolves slowly in the mouth for absorption through the oral mucosa. This method of administration allows for targeted local or systemic effects. It is crucial to follow your doctor's instructions when taking this medication. If you have any questions or concerns about this medication, please consult your healthcare provider.
This is a compounded medication that contains a combination of hormones including Estriol, Estradiol, Estrone, Progesterone, and Testosterone. It is designed to be taken orally and dissolves slowly in the mouth for absorption through the oral mucosa.
This formulation is typically used for hormone replacement therapy. It can help to balance hormone levels in the body and alleviate symptoms associated with hormonal imbalances, such as those experienced during menopause.
This medication is a troche, which means it should be placed in the mouth and allowed to dissolve slowly. It is not meant to be swallowed whole or chewed.
The dosage form refers to the physical form of a dose of medication. In this case, the medication is a square-shaped solid that dissolves slowly in the mouth.
Oral mucosa absorption allows the medication to enter the bloodstream directly, bypassing the digestive system. This can result in a faster onset of action and potentially fewer gastrointestinal side effects.
As with any medication, potential side effects can occur. These may include mood changes, weight changes, headaches, and changes in libido. Always consult with your healthcare provider for a complete list of potential side effects.
It is important to consult with your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding before starting any new medication, including this compounded formulation.
If you miss a dose, take it as soon as you remember. If it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take two doses at the same time.
It is generally recommended to avoid alcohol while taking this medication as it may interfere with its effectiveness and can potentially increase the risk of side effects.
This medication should be stored at room temperature, away from light and moisture. Keep out of reach of children and pets.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Place 1 troche between cheek and gum and let slowly dissolve
